There are still debated about surveillance interval, duration, diagnostic modality and treatment for intraductal papillary mucinous neoplasm (IPMN) of the pancreas. In recent guidelines, ‘high risk stigmata (HRS)’ ‘worrisome feature (WF)’ defined as predictive factors malignancy in IPMN. IPMNs with HRS main duct- IPMN more likely to accompany malignancies, thus require surgery. However, case on...
